Search

everythinglearnresearchcommunity

for

Search:↓

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Alopecia frontal fibrosante affects facial vellus hair and can be diagnosed with dermatoscopy.

Large-scale fibronectin nanofibers help heal wounds and repair tissue in a skin model of a mouse.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

Fipronil effectively treats Lynxacarus radovskyi in outdoor cats.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

PDO threads improve skin firmness and elasticity with minimal recovery time.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Finasteride may cause floppy-iris syndrome during cataract surgery, so check patients' medical history.

Erlotinib can cause unexpected side effects like eyelash growth and scarring.

PRP injections improve periorbital wrinkles and show promise as a treatment.

Face-lifts can lead to complications like bleeding, nerve injury, skin death, hair loss, and rare infections, with careful surgery reducing risks.

Blocking JAK-STAT signaling can lead to hair growth.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Sunscreen use is linked to frontal fibrosing alopecia, especially in males.

The cream effectively and safely reduces facial hair in women.

Hyaluronic acid filler and fat grafting can cause rare skin complications.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

Ritlecitinib is safe and may effectively treat alopecia areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The herbal preparation may help manage alopecia by reducing inflammation and boosting the immune response.

Using superficial temporal fascia helps prevent Frey syndrome after parotid surgery.

Upadacitinib improved multiple immune-related conditions in one patient.